These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 10657966)

  • 21. Leukotriene A4 hydrolase in rat and human esophageal adenocarcinomas and inhibitory effects of bestatin.
    Chen X; Li N; Wang S; Wu N; Hong J; Jiao X; Krasna MJ; Beer DG; Yang CS
    J Natl Cancer Inst; 2003 Jul; 95(14):1053-61. PubMed ID: 12865451
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The sequential model of Barrett's esophagus and adenocarcinoma induced by duodeno-esophageal reflux without exogenous carcinogens.
    Sato T; Miwa K; Sahara H; Segawa M; Hattori T
    Anticancer Res; 2002; 22(1A):39-44. PubMed ID: 12017320
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Involvement of oxidative stress in experimentally induced reflux esophagitis and esophageal cancer.
    Inayama M; Hashimoto N; Tokoro T; Shiozaki H
    Hepatogastroenterology; 2007; 54(75):761-5. PubMed ID: 17591057
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Overexpression of glucose-regulated protein 94 (Grp94) in esophageal adenocarcinomas of a rat surgical model and humans.
    Chen X; Ding Y; Liu CG; Mikhail S; Yang CS
    Carcinogenesis; 2002 Jan; 23(1):123-30. PubMed ID: 11756233
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of freeze-dried berries on the development of reflux-induced esophageal adenocarcinoma.
    Aiyer HS; Li Y; Losso JN; Gao C; Schiffman SC; Slone SP; Martin RC
    Nutr Cancer; 2011 Nov; 63(8):1256-62. PubMed ID: 22043833
    [TBL] [Abstract][Full Text] [Related]  

  • 26. DNA Damage in CD133-Positive Cells in Barrett's Esophagus and Esophageal Adenocarcinoma.
    Thanan R; Ma N; Hiraku Y; Iijima K; Koike T; Shimosegawa T; Murata M; Kawanishi S
    Mediators Inflamm; 2016; 2016():7937814. PubMed ID: 27069317
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Changing role of in vivo models in columnar-lined lower esophagus.
    Koak Y; Winslet M
    Dis Esophagus; 2002; 15(4):271-7. PubMed ID: 12472470
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Animal Model: Reflux Models in Esophageal Adenocarcinoma.
    Masuda T; Mittal SK
    Methods Mol Biol; 2018; 1756():143-150. PubMed ID: 29600367
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Alteration of Esophageal Microbiome by Antibiotic Treatment Does Not Affect Incidence of Rat Esophageal Adenocarcinoma.
    Sawada A; Fujiwara Y; Nagami Y; Tanaka F; Yamagami H; Tanigawa T; Shiba M; Tominaga K; Watanabe T; Gi M; Wanibuchi H; Arakawa T
    Dig Dis Sci; 2016 Nov; 61(11):3161-3168. PubMed ID: 27461059
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [A COX-2 inhibitor suppresses esophageal inflammation-metaplasia-adenocarcinoma sequence in rats].
    Miwa K; Oyama K; Fujimura T
    Nihon Rinsho; 2005 Aug; 63(8):1387-93. PubMed ID: 16101227
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Simultaneous progression of oxidative stress and angiogenesis in malignant transformation of Barrett esophagus.
    Sihvo EI; Ruohtula T; Auvinen MI; Koivistoinen A; Harjula AL; Salo JA
    J Thorac Cardiovasc Surg; 2003 Dec; 126(6):1952-7. PubMed ID: 14688711
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Duodenal juice stimulates oesophageal stem cells to induce Barrett's oesophagus and oesophageal adenocarcinoma in rats.
    Miyashita T; Ohta T; Fujimura T; Ninomiya I; Fushida S; Hattori T; Miwa K
    Oncol Rep; 2006 Jun; 15(6):1469-75. PubMed ID: 16685381
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Expression profiles of cancer stem cell markers: CD133, CD44, Musashi-1 and EpCAM in the cardiac mucosa-Barrett's esophagus-early esophageal adenocarcinoma-advanced esophageal adenocarcinoma sequence.
    Mokrowiecka A; Veits L; Falkeis C; Musial J; Kordek R; Lochowski M; Kozak J; Wierzchniewska-Lawska A; Vieth M; Malecka-Panas E
    Pathol Res Pract; 2017 Mar; 213(3):205-209. PubMed ID: 28216140
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The Role of Esophagogastroduodenoscopy Surveillance for Patients with Barrett Esophagus.
    Palamara K
    Med Clin North Am; 2016 Sep; 100(5):1057-64. PubMed ID: 27542425
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Selective decrease in the DNA base excision repair pathway in squamous cell cancer of the esophagus.
    Bonde P; Gao D; Chen L; Duncan M; Miyashita T; Montgomery E; Harmon JW; Wei C
    J Thorac Cardiovasc Surg; 2007 Jan; 133(1):74-81. PubMed ID: 17198784
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Serial Endoscopic Evaluation of Esophageal Disease in a Cancer Model: A Paradigm Shift for Esophageal Adenocarcinoma (EAC) Drug Discovery and Development.
    Omstead AN; Kosovec JE; Matsui D; Martin SA; Smith MA; Aaron Guel D; Kolano J; Komatsu Y; Habib F; Lai C; Christopher K; Kelly RJ; Zaidi AH; Jobe BA
    Cancer Invest; 2018; 36(7):363-370. PubMed ID: 30142016
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Esophageal adenocarcinoma: a review and perspectives on the mechanism of carcinogenesis and chemoprevention.
    Chen X; Yang CS
    Carcinogenesis; 2001 Aug; 22(8):1119-29. PubMed ID: 11470739
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Open questions in oesophageal adenocarcinogenesis.
    Maley CC
    Gut; 2007 Jul; 56(7):897-8. PubMed ID: 17566022
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cardiac mucosa indicates risk for Barrett esophagus.
    Lenglinger J; Ringhofer C; Riegler FM
    World J Gastroenterol; 2006 Aug; 12(32):5259. PubMed ID: 16937547
    [No Abstract]   [Full Text] [Related]  

  • 40. Influence of surgically induced gastric and gastroduodenal content reflux on esophageal carcinogenesis--experimental model in Wistar female rats.
    Melo LL; Kruel CD; Kliemann LM; Cavazzola LT; Boeno Rda L; Silber PC; Grossi RS
    Dis Esophagus; 1999; 12(2):106-15. PubMed ID: 10466042
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.